We then explored the distribution of NDUFA4L2 among the scRNA‐seq cohorts of breast cancer patients, and we found that NDUFA4L2 was mainly expressed in fibroblasts, epithelial cells, and endothelial cells (Figure S2D). The gene discussed is COXFA4L2; the disease is breast carcinoma.